Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), explains how COA plays a role in supporting practices in preparing for Oncology Care Model.
Bo Gamble, director of Strategic Practice Initiatives at the Community Oncology Alliance (COA), explains how COA plays a role in supporting practices in preparing for Oncology Care Model.
Transcript
How has COA played a role in helping smaller practices prepare for OCM?
We’re trying to create a platform for dialogue. What we’ve found historically—even Medicare, for example, is 50 years, it’s the same program over and over again—payers do the same thing over and over again. Even when you’re an employer and you’re like, "Here’s your benefit package," and you’re like, "Ahh" or "It’s okay, but the premiums are going up." We got to change this concept because we’re just going in the opposite direction.
So the notion of this program, and we have been working on reform now for 6 or 7 years, the [COA Payer Exchange Summit] is a platform is to engage the others. So if you’re part of a care team, the price of admission you must bring a payer or employer and if you’re a payer or employer looking for options you got to bring someone in from a care team. The concept is helping to bring down the walls and it’s exciting because we’re in a place where we’re talking about a place where we’ve never talked before. We haven’t figured it out yet but we’re making progress.
If you look at 6 years ago, the buzzword was pathways, pathways, pathways. It became a component, but it’s not the component. Which is good. There’s other things and we continue to get smarter about what we think’s important in care, in quality, in value and we’re starting to agree on come components. Now the trick is let’s do it efficiently, so it’s the same model, we’re just changing how it’s looked. We have to change optics because there’s still those little fires that pop up, that says, "Here’s what we’re doing," and their motive and their incentive or their understanding is just way off base. So we have a lot of education to do.
Cellular Therapies in Lymphoma Bring Hope, but Optimizing Their Use Remains a Challenge
December 10th 2023Recent decades have seen marked improvements in hematological cancer outcomes and an expanded armamentarium of therapies, but novel treatments require updated strategies that are not always easy to fine-tune, according to presenters at the 2023 American Society of Hematology Annual Meeting and Exposition.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More